Search Results

There are 17253 results for: content related to: Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients

  1. Final results of a phase 2 trial of clofarabine and low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia

    Cancer

    Volume 121, Issue 14, July 15 2015, Pages: 2375–2382, Tapan M. Kadia, Stefan Faderl, Farhad Ravandi, Elias Jabbour, Guillermo Garcia-Manero, Gautam Borthakur, Alessandra Ferrajoli, Marina Konopleva, Jan Burger, Xuelin Huang, Xuemei Wang, Sherry Pierce, Mark Brandt, Jennie Feliu, Jorge Cortes and Hagop Kantarjian

    Article first published online : 25 MAR 2015, DOI: 10.1002/cncr.29367

  2. A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of age

    British Journal of Haematology

    Volume 170, Issue 3, August 2015, Pages: 349–355, Sarah A. Buckley, Raya Mawad, Ted A. Gooley, Pamela S. Becker, Vicky Sandhu, Paul Hendrie, Bart L. Scott, Brent L. Wood, Roland B. Walter, Kelly Smith, Carol Dean, Elihu H. Estey and John M. Pagel

    Article first published online : 8 APR 2015, DOI: 10.1111/bjh.13437

  3. G-CSF Priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm

    American Journal of Hematology

    Volume 90, Issue 4, April 2015, Pages: 295–300, Pamela S. Becker, Bruno C. Medeiros, Anthony S. Stein, Megan Othus, Frederick R. Appelbaum, Stephen J. Forman, Bart L. Scott, Paul C. Hendrie, Kelda M. Gardner, John M. Pagel, Roland B. Walter, Cynthia Parks, Brent L. Wood, Janis L. Abkowitz and Elihu H. Estey

    Article first published online : 30 JAN 2015, DOI: 10.1002/ajh.23927

  4. You have free access to this content
    ASH 2010 meeting report—Top 10 clinically oriented abstracts in acute leukemia

    American Journal of Hematology

    Volume 86, Issue 5, May 2011, Pages: 454–457, Amber Fullmer, Jorge Cortes, Hagop Kantarjian and Elias Jabbour

    Article first published online : 26 APR 2011, DOI: 10.1002/ajh.21998

  5. Feasibility and efficacy of outpatient therapy with intermediate dose cytarabine, fludarabine and idarubicin for patients with acute myeloid leukaemia aged 70 or older

    European Journal of Haematology

    Susana Vives, Albert Oriol, Sònia Piernas, Salut Brunet, Victòria Clapés, Ramon Guardia, Maricel Subirà, Jordi Sierra, Josep-Maria Ribera and on behalf of the CETLAM Group

    Article first published online : 16 MAR 2015, DOI: 10.1111/ejh.12538

  6. You have free access to this content
    Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia

    British Journal of Haematology

    Volume 155, Issue 2, October 2011, Pages: 182–189, Pamela S. Becker, Hagop M. Kantarjian, Frederick R. Appelbaum, Stephen H. Petersdorf, Barry Storer, Sherry Pierce, Jianqin Shan, Paul C. Hendrie, John M. Pagel, Andrei R. Shustov, Derek L. Stirewalt, Stephan Faderl, Elizabeth Harrington and Elihu H. Estey

    Article first published online : 18 AUG 2011, DOI: 10.1111/j.1365-2141.2011.08831.x

  7. You have free access to this content
    The role of clofarabine in hematologic and solid malignancies—Development of a next-generation nucleoside analog

    Cancer

    Volume 103, Issue 10, 15 May 2005, Pages: 1985–1995, Stefan Faderl, Varsha Gandhi, Michael J. Keating, Sima Jeha, William Plunkett and Hagop M. Kantarjian

    Article first published online : 31 MAR 2005, DOI: 10.1002/cncr.21005

  8. Valproic acid synergistically enhances the cytotoxicity of clofarabine in pediatric acute myeloid leukemia cells

    Pediatric Blood & Cancer

    Volume 59, Issue 7, 15 December 2012, Pages: 1245–1251, Chengzhi Xie, Holly Edwards, Salvatore B. LoGrasso, Steven A. Buck, Larry H. Matherly, Jeffrey W. Taub and Yubin Ge

    Article first published online : 5 APR 2012, DOI: 10.1002/pbc.24152

  9. You have free access to this content
    Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients

    American Journal of Hematology

    Volume 87, Issue 12, December 2012, Pages: 1047–1051, Barbara Scappini, Giacomo Gianfaldoni, Francesco Caracciolo, Francesco Mannelli, Caterina Biagiotti, Claudio Romani, Enrico M. Pogliani, Federico Simonetti, Lorenza Borin, Rosa Fanci, Ilaria Cutini, Giovanni Longo, Maria Chiara Susini, Emanuele Angelucci and Alberto Bosi

    Article first published online : 1 AUG 2012, DOI: 10.1002/ajh.23308

  10. You have free access to this content
    Clinical and proteomic characterization of acute myeloid leukemia with mutated RAS

    Cancer

    Volume 118, Issue 22, 15 November 2012, Pages: 5550–5559, Tapan M. Kadia, Hagop Kantarjian, Steven Kornblau, Gautam Borthakur, Stefan Faderl, Emil J. Freireich, Raja Luthra, Guillermo Garcia-Manero, Sherry Pierce, Jorge Cortes and Farhad Ravandi

    Article first published online : 8 MAY 2012, DOI: 10.1002/cncr.27596

  11. You have full text access to this OnlineOpen article
    Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemia

    Cancer Medicine

    Volume 3, Issue 6, December 2014, Pages: 1570–1578, Santhosh K. Sadashiv, Christie Hilton, Cyrus Khan, James M. Rossetti, Heather L. Benjamin, Salman Fazal, Entezam Sahovic, Richard K. Shadduck and John Lister

    Article first published online : 15 AUG 2014, DOI: 10.1002/cam4.321

  12. You have free access to this content
    Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia

    American Journal of Hematology

    Volume 88, Issue 11, November 2013, Pages: 961–966, Aziz Nazha, Hagop Kantarjian, Farhad Ravandi, Xuelin Huang, Sangbum Choi, Guillermo Garcia-Manero, Elias Jabbour, Gautam Borthakur, Tapan Kadia, Marina Konopleva, Jorge Cortes, Alessandra Ferrajoli, Steve Kornblau, Naval Daver, Naveen Pemmaraju, Michael Andreeff, Zeev Estrov, Min Du, Mark Brandt and Stefan Faderl

    Article first published online : 9 SEP 2013, DOI: 10.1002/ajh.23544

  13. Salvage Therapy for Acute Myeloid Leukemia: Current Strategies and Emerging Therapies

    Leukemias: Principles and Practice of Therapy

    Keith W. Pratz, Judith E. Karp, Pages: 138–147, 2011

    Published Online : 4 JAN 2011, DOI: 10.1002/9781444327359.ch11

  14. Phase I dose-escalation trial of clofarabine followed by escalating doses of fractionated cyclophosphamide in children with relapsed or refractory acute leukemias

    Pediatric Blood & Cancer

    Volume 59, Issue 7, 15 December 2012, Pages: 1252–1258, Abeer Abd Elmoneim, Lia Gore, Rebecca M. Ricklis, Jessica Boklan, Todd Cooper, Aru Narendran, Katherine Rolla, Tammy Scott and Robert J. Arceci

    Article first published online : 8 AUG 2012, DOI: 10.1002/pbc.24264

  15. You have free access to this content
    Progress in the treatment of acute myeloid leukemia

    Cancer

    Volume 110, Issue 9, 1 November 2007, Pages: 1900–1910, Farhad Ravandi, Alan K. Burnett, Edward D. Agura and Hagop M. Kantarjian

    Article first published online : 4 SEP 2007, DOI: 10.1002/cncr.23000

  16. You have free access to this content
    Clofarabine in combination with pegylated asparaginase in the frontline treatment of childhood acute lymphoblastic leukaemia: a feasibility report from the CoALL 08-09 trial

    British Journal of Haematology

    Volume 163, Issue 2, October 2013, Pages: 240–247, Gabriele Escherich, Udo zur Stadt, Martin Zimmermann, Martin A. Horstmann and on behalf of the CoALL study group

    Article first published online : 12 AUG 2013, DOI: 10.1111/bjh.12520

  17. You have full text access to this Open Access content
    Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells

    EMBO Molecular Medicine

    Volume 4, Issue 7, July 2012, Pages: 577–593, Luigi Leanza, Brian Henry, Nicola Sassi, Mario Zoratti, K. George Chandy, Erich Gulbins and Ildikò Szabò

    Article first published online : 11 APR 2012, DOI: 10.1002/emmm.201200235

  18. Pharmacokinetics of Clofarabine in Patients With High-Risk Inherited Metabolic Disorders Undergoing Brain-Sparing Hematopoietic Cell Transplantation

    The Journal of Clinical Pharmacology

    Volume 51, Issue 5, May 2011, Pages: 679–686, Dr Janel Long-Boyle, Dr Jiayin Huang, Dr Nancy Rydholm, Dr Angela Smith, Dr Paul Orchard, Dr Jakub Tolar and Dr Pamala Jacobson

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270010372519

  19. Clofarabine salvage therapy for refractory high-risk langerhans cell histiocytosis

    Pediatric Blood & Cancer

    Volume 60, Issue 6, June 2013, Pages: E19–E22, Allistair Abraham, Abdulrahman Alsultan, Michael Jeng, Carlos Rodriguez-Galindo and Patrick K. Campbell

    Article first published online : 19 DEC 2012, DOI: 10.1002/pbc.24436

  20. Induction Therapy of Acute Myeloid Leukemia

    Leukemias: Principles and Practice of Therapy

    Martha Wadleigh, Daniel J. Deangelo, Pages: 125–137, 2011

    Published Online : 4 JAN 2011, DOI: 10.1002/9781444327359.ch10